Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 HKD | +0.85% | +0.85% | +13.33% |
Mar. 26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
Mar. 25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
Sales 2022 | 1.28B 177M 1.38B | Sales 2023 | 1.15B 159M 1.25B | Capitalization | 1.43B 198M 1.55B |
---|---|---|---|---|---|
Net income 2022 | 358M 49.59M 387M | Net income 2023 | 326M 45.16M 353M | EV / Sales 2022 | 0.54 x |
Net cash position 2022 | 1.07B 149M 1.16B | Net cash position 2023 | 1.05B 146M 1.14B | EV / Sales 2023 | 0.33 x |
P/E ratio 2022 |
4.93
x | P/E ratio 2023 |
4.4
x | Employees | 1,143 |
Yield 2022 |
6.63% | Yield 2023 |
7.61% | Free-Float | 39.97% |
1 day | +0.85% | ||
1 week | +0.85% | ||
Current month | +0.85% | ||
3 months | +9.17% | ||
6 months | +9.17% | ||
Current year | +13.33% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 22-02-15 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 02-11-30 |
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 02-09-30 |
Hong Man Leung
BRD | Director/Board Member | 49 | 05-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.19 | +0.85% | 268,000 |
24-05-08 | 1.18 | 0.00% | 296,000 |
24-05-07 | 1.18 | -1.67% | 196,000 |
24-05-06 | 1.2 | +1.69% | 396,000 |
24-05-03 | 1.18 | +0.85% | 356,000 |
Delayed Quote Hong Kong S.E., May 09, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.33% | 226M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- 2348 Stock